SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
Form
6-K
REPORT
OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES
EXCHANGE ACT OF 1934
For the
month of February, 2011.
Commission
File Number 000-51341
|
Gentium S.p.A.
|
|
(Translation
of registrant’s name into
English)
|
Piazza XX Settembre 2, 22079 Villa Guardia (Como),
Italy
|
|
(Address
of principal executive
office)
|
Indicate
by check mark whether the registrant files or will file annual reports under
cover of Form 20-F or Form 40-F.
Form 20-F
S Form
40-F o
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted
by Regulation S-T Rule 101(b)(1): ____
Note: Regulation S-T Rule
101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely
to provide an attached annual report to security holders.
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted
by Regulation S-T Rule 101(b)(7): ____
Note: Regulation S-T Rule
101(b)(7) only permits the submission in paper of a Form 6-K if submitted to
furnish a report or other document that the registrant foreign private issuer
must furnish and make public under the laws of the jurisdiction in which the
registrant is incorporated, domiciled or legally organized (the registrant’s
“home country”), or under the rules of the home country exchange on which the
registrant’s securities are traded, as long as the report or other document is
not a press release, is not required to be and has not been distributed to the
registrant’s security holders, and, if discussing a material event, has already
been the subject of a Form 6-K submission or other Commission filing on
EDGAR.
Indicate
by check mark whether the registrant by furnishing the information contained in
this Form is also thereby furnishing the information to the Commission pursuant
to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes o No S
If “Yes”
is marked, indicate below the file number assigned to the registrant in
connection with Rule 12g3-2(b):
82-_______________.
The
Registrant's press release regarding the completion of preclinical and clinical
studies for Defibrotide is attached hereto as Exhibit 1 and incorporated by
reference herein in its entirety. This report and the exhibit
attached thereto are incorporated by reference into the registration statements
of Gentium S.p.A. on Forms F-3: File No. 333-135622, File No.
333-137551, File No. 333-138202, File No. 333-139422, File No. 333-141198, and
File No. 333-171443 and on Forms S-8: File No. 333-137534 and File No.
333-146534.
Exhibit Description
1 Press
release, dated February 8, 2011.
SIGNATURE
Pursuant to the requirements of the
Securities Exchange Act of 1934, the registrant has duly caused this report to
be signed on its behalf by the undersigned thereunto duly
authorized.
| |
GENTIUM
S.P.A |
|
| |
|
|
|
|
|
By:
|
/s/ Salvatore
Calabrese |
|
| |
|
Name: Salvatore
Calabrese |
|
| |
|
Title: Chief
Financial Officer and Senior VP |
|
| |
|
|
|
Date:
February 8, 2011
INDEX
TO EXHIBITS
Exhibit Description
1 Press
release, dated February 8, 2011.